These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
332 related articles for article (PubMed ID: 29381773)
1. Association of circulating CTRP9 with soluble adhesion molecules and inflammatory markers in patients with type 2 diabetes mellitus and coronary artery disease. Moradi N; Fadaei R; Emamgholipour S; Kazemian E; Panahi G; Vahedi S; Saed L; Fallah S PLoS One; 2018; 13(1):e0192159. PubMed ID: 29381773 [TBL] [Abstract][Full Text] [Related]
2. Circulating C1q complement/TNF-related protein (CTRP) 1, CTRP9, CTRP12 and CTRP13 concentrations in Type 2 diabetes mellitus: In vivo regulation by glucose. Bai B; Ban B; Liu Z; Zhang MM; Tan BK; Chen J PLoS One; 2017; 12(2):e0172271. PubMed ID: 28207876 [TBL] [Abstract][Full Text] [Related]
3. Associations of C1q/TNF-Related Protein-9 Levels in Serum and Epicardial Adipose Tissue with Coronary Atherosclerosis in Humans. Wang J; Hang T; Cheng XM; Li DM; Zhang QG; Wang LJ; Peng YP; Gong JB Biomed Res Int; 2015; 2015():971683. PubMed ID: 26457306 [TBL] [Abstract][Full Text] [Related]
4. Role of CTRP3, CTRP9 and MCP-1 for the evaluation of T2DM associated coronary artery disease in Egyptian postmenopausal females. Ahmed SF; Shabayek MI; Abdel Ghany ME; El-Hefnawy MH; El-Mesallamy HO PLoS One; 2018; 13(12):e0208038. PubMed ID: 30557342 [TBL] [Abstract][Full Text] [Related]
5. Lower serum levels of Meteorin-like/Subfatin in patients with coronary artery disease and type 2 diabetes mellitus are negatively associated with insulin resistance and inflammatory cytokines. Dadmanesh M; Aghajani H; Fadaei R; Ghorban K PLoS One; 2018; 13(9):e0204180. PubMed ID: 30212581 [TBL] [Abstract][Full Text] [Related]
6. Association of serum C1q/TNF-related protein-9 concentration with arterial stiffness in subjects with type 2 diabetes. Jung CH; Lee MJ; Kang YM; Jang JE; Leem J; Lee YL; Seol SM; Yoon HK; Lee WJ; Park JY J Clin Endocrinol Metab; 2014 Dec; 99(12):E2477-84. PubMed ID: 25105737 [TBL] [Abstract][Full Text] [Related]
7. Plasma C1q/TNF-related protein 9: a promising biomarker for diabetic renal vascular injury. Fujita T; Watanabe H; Murata Y; Hemmi S; Yabuki M; Fuke Y; Satomura A; Soma M Minerva Urol Nefrol; 2017 Apr; 69(2):195-200. PubMed ID: 26633552 [TBL] [Abstract][Full Text] [Related]
8. Association of C1q/TNF-Related Protein-3 (CTRP3) and CTRP13 Serum Levels with Coronary Artery Disease in Subjects with and without Type 2 Diabetes Mellitus. Fadaei R; Moradi N; Baratchian M; Aghajani H; Malek M; Fazaeli AA; Fallah S PLoS One; 2016; 11(12):e0168773. PubMed ID: 28033351 [TBL] [Abstract][Full Text] [Related]
9. Association of serum C1q/TNF-Related Protein-9 (CTRP9) concentration with visceral adiposity and metabolic syndrome in humans. Hwang YC; Woo Oh S; Park SW; Park CY Int J Obes (Lond); 2014 Sep; 38(9):1207-12. PubMed ID: 24357853 [TBL] [Abstract][Full Text] [Related]
10. Circulating CTRP9 levels are increased in patients with newly diagnosed type 2 diabetes and correlated with insulin resistance. Jia Y; Luo X; Ji Y; Xie J; Jiang H; Fu M; Li X Diabetes Res Clin Pract; 2017 Sep; 131():116-123. PubMed ID: 28743061 [TBL] [Abstract][Full Text] [Related]
11. High sensitive C-reactive protein, adiponectin, and urine albumin excretion rate in Chinese coronary artery disease patients with different glucose tolerance status. Gui MH; Hong J; Lü AK; Chen Y; Shen WF; Li XY; Ning G Chin Med J (Engl); 2008 Dec; 121(24):2509-16. PubMed ID: 19187587 [TBL] [Abstract][Full Text] [Related]
14. Comparison of plasma adiponectin & certain inflammatory markers in angiographically proven coronary artery disease patients with & without diabetes--a study from India. Kumpatla S; Karuppiah K; Immaneni S; Muthukumaran P; Krishnan J; Narayanamoorthy SK; Viswanathan V Indian J Med Res; 2014 Jun; 139(6):841-50. PubMed ID: 25109718 [TBL] [Abstract][Full Text] [Related]
15. Association of serum glycated albumin, C-reactive protein and ICAM-1 levels with diffuse coronary artery disease in patients with type 2 diabetes mellitus. Jin C; Lu L; Zhang RY; Zhang Q; Ding FH; Chen QJ; Shen WF Clin Chim Acta; 2009 Oct; 408(1-2):45-9. PubMed ID: 19615354 [TBL] [Abstract][Full Text] [Related]
16. Differential associations of circulating asymmetric dimethylarginine and cell adhesion molecules with metformin use in patients with type 2 diabetes mellitus and stable coronary artery disease. Kruszelnicka O; Chyrchel B; Golay A; Surdacki A Amino Acids; 2015 Sep; 47(9):1951-9. PubMed ID: 25859650 [TBL] [Abstract][Full Text] [Related]
17. Serum protein signature of coronary artery disease in type 2 diabetes mellitus. Adela R; Reddy PNC; Ghosh TS; Aggarwal S; Yadav AK; Das B; Banerjee SK J Transl Med; 2019 Jan; 17(1):17. PubMed ID: 30674322 [TBL] [Abstract][Full Text] [Related]
18. Imbalanced low-grade inflammation and endothelial activation in patients with type 2 diabetes mellitus and erectile dysfunction. Araña Rosaínz Mde J; Ojeda MO; Acosta JR; Elías-Calles LC; González NO; Herrera OT; García Álvarez CT; Rodríguez EM; Báez ME; Seijas EÁ; Valdés RF J Sex Med; 2011 Jul; 8(7):2017-30. PubMed ID: 21554550 [TBL] [Abstract][Full Text] [Related]
19. Inflammatory markers in a 2-year follow-up of coronary artery disease. Mizia-Stec K; Gasior Z; Zahorska-Markiewicz B; Holecki M; Kumor P Heart Vessels; 2006 Sep; 21(5):302-8. PubMed ID: 17151818 [TBL] [Abstract][Full Text] [Related]
20. [Association between serum CTRP9 levels and diabetic retinopathy in patients with type 2 diabetes mellitus]. Zhou P; Liu L; Gao W Nan Fang Yi Ke Da Xue Xue Bao; 2021 Mar; 41(3):459-463. PubMed ID: 33849840 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]